Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme-Reference-Cited by-同舟云学术

Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme

Published:2017-01-09 Issue:3 Volume:37 Page:259-272
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Kimutai Robert^ORCID,Musa Ahmed M.,Njoroge Simon,Omollo Raymond,Alves Fabiana,Hailu Asrat,Khalil Eltahir A. G.,Diro Ermias,Soipei Peninah,Musa Brima,Salman Khalid,Ritmeijer Koert,Chappuis Francois,Rashid Juma,Mohammed Rezika,Jameneh Asfaw,Makonnen Eyasu,Olobo Joseph,Okello Lawrence,Sagaki Patrick,Strub Nathalie,Ellis Sally,Alvar Jorge,Balasegaram Manica,Alirol Emilie,Wasunna Monique

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40261-016-0481-0.pdf

Reference45 articles.

1. Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol. 2007;5(11):S7–16.

2. Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7(5):e35671.

3. Paul R. Epidemiology of visceral leishmaniasis. Clin Epidemiol. 2016;(May 2014):147–54.

4. Pearson RD, Sousa ADQ. Clinical spectrum of leishmaniasis. Clin Infect Dis. 1995;1996(22):1–13.

5. Seaman J, Mercer AJ, Sondorp E. The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994. Int J Epidemiol. 1996;25(4):862–71.

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease-Specific Differences in Pharmacokinetics of Paromomycin and Miltefosine Between Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Patients in Eastern Africa;The Journal of Infectious Diseases;2024-08-21

2. Exploration of Antileishmanial Compounds Derived from Natural Sources;Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry;2024-03

3. Inhibition and structural insights of leishmanial glutamyl-tRNA synthetase for designing potent therapeutics;International Journal of Biological Macromolecules;2024-01

4. Leishmaniasis;Manson's Tropical Diseases;2024

5. The status of combination therapy for visceral leishmaniasis: an updated review;The Lancet Infectious Diseases;2023-08